
Your job-based insurance cut GLP-1 coverage. Here are some options
Media coverage: David Clement is quoted in this USA TODAY article.
Ken Alltucker’s report looks at how employers such as Starbucks, PepsiCo and Cigna are pulling back insurance coverage of GLP-1 weight-loss drugs like Wegovy and Zepbound, leaving some workers to cover steep out-of-pocket costs. Surveys cited in the piece show fewer large employers covering the drugs for obesity this year, with cost the main reason companies give. It also outlines options for people who lose coverage, including buying directly from the drugmakers or through telehealth providers.
The article quotes David Clement, policy director of the Consumer Choice Center, on what the pullback could mean for prices:
Employers like Starbucks dropping coverage for these drugs means a larger cash market, which means downward pressure on prices.
Quoted in USA TODAY, by Ken Alltucker.